Biotechnology: The Patenting of DNA Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology: The Patenting of DNA

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote ()	5/14/1999 7:21:00 PM
From: mike head	Read Replies (2) of 37

Mike... been awhile , and this thread is too quiet! I guess Jomathen Rothberg should get the audacity award of the year for Curagen! Pax et Bonum, mch NEW HAVEN, Conn., May 6 /PRNewswire/ -- CuraGen Corporation (Nasdaq: CRGN), an integrated genomics-based drug discovery and development company, announced today the public opening of the Company's GeneScape Portal(TM); an Internet portal that provides web-based access to the tools and databases necessary for datamining, managing workflow, and conducting genomics experiments over the Internet. In order to drive future strategic business and academic collaborations, CuraGen is providing secure access to potential worldwide partners for the purpose of directly evaluating these research tools, interfaces, and databases. Through CuraTools(TM), CuraGen's suite of genomics data analysis software, the Company is linking select information from its proprietary databases with publicly available information from sources such as the Human Genome Project and the SNP Consortium database which are currently under development. CuraTools is accessible through the GeneScape Portal located on the Internet at curagen.com.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next